News Alcon Pulls CyPass Glaucoma Micro-Stent Off the Global Market by Medscape • 2018/08/31 • 0 Comments The company cites 5-year safety data that show statistically significant endothelial cell loss in patients who received the CyPass stent at the time of glaucoma surgery. News Alerts Full Story →